Dow Up0.26% Nasdaq Down1.07%

ACADIA Pharmaceuticals Inc. (ACAD)

-NasdaqGS
26.79 1.45(5.13%) Sep 15, 3:59PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 1,145   4,907   2,067  
Cost of Revenue -   -   -  
Gross Profit 1,145   4,907   2,067  
Operating Expenses
Research Development26,722  18,794  17,309  
Selling General and Administrative12,720  6,999  7,610  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (38,297) (20,886) (22,852)
Income from Continuing Operations
Total Other Income/Expenses Net349  37  87  
Earnings Before Interest And Taxes(37,948)(20,849)(22,765)
Interest Expense -   -   -  
Income Before Tax(37,948)(20,849)(22,765)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(37,948)(20,849)(22,765)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (37,948) (20,849) (22,765)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (37,948) (20,849) (22,765)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.